Ravi Yang Sarin Oncology Institute, Inc. (TOI) insider trading activity

TOI Quotes by TradingView

Ravi Yang Sarin is Director of Oncology Institute, Inc.. Currently has a direct ownership of 75,427 shares of TOI, which is worth approximately $15,839. The most recent transaction as insider was on Mar 17, 2023, when has been sold 29,528 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.4K
0% 3M change
0% 12M change
Total Value Held $15,839

RAVI YANG SARIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2023
BUY
Grant, award, or other acquisition
-
29,528 Added 28.13%
75,427 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
22,708 Added 33.1%
45,899 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
23,191 Added 50.0%
23,191 Common Stock
RYS

Ravi Yang Sarin

Director
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TOI